{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:17:57Z","timestamp":1778897877354,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100016623","name":"Radiation Oncology Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016623","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.prro.2024.05.010","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T14:13:31Z","timestamp":1721052811000},"page":"574-581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["International Federation of Gynecology and Obstetrics Endometrial 2023 Is Better For Radiation Oncology Patients"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5752-1611","authenticated-orcid":false,"given":"David","family":"Gaffney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gita","family":"Suneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Weil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carien","family":"Creutzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2024.05.010_bib0001","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.prro.2024.05.010_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.113913","article-title":"Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer","volume":"201","author":"Gravbrot","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2024.05.010_bib0003","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ygyno.2023.05.069","article-title":"The right time for change: a report on the heterogeneity of IVB endometrial cancer and improved risk-stratification provided by new 2023 FIGO staging criteria","volume":"175","author":"Haight","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2024.05.010_bib0004","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2024.35.e59","article-title":"The new 2023 FIGO staging system for endometrial cancer: what is different from the previous 2009 FIGO staging system?","author":"Han","year":"2024","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.prro.2024.05.010_bib0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2023.09.011","article-title":"Utility of the revised FIGO2023 staging with molecular classification in endometrial cancer","volume":"178","author":"Kobayashi-Kato","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2024.05.010_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113316","article-title":"Validation of the 2023 FIGO staging schema for advanced endometrial cancer","volume":"193","author":"Matsuo","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2024.05.010_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113317","article-title":"Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - an international pooled analysis of three ESGO accredited centres","volume":"193","author":"Schwameis","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2024.05.010_bib0008","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ygyno.2024.01.040","article-title":"2023 changes to FIGO endometrial cancer staging: counterpoint","volume":"184","author":"Leitao","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2024.05.010_bib0009","article-title":"FIGO 2023 endometrial cancer staging: too much, too soon?","author":"McCluggage","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2024.05.010_bib0010","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1200\/JCO.23.00062","article-title":"Molecular classification predicts response to radiotherapy in the randomized PORTEC-1 and PORTEC-2 trials for early-stage endometrioid endometrial cancer","volume":"41","author":"Horeweg","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.010_bib0011","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Leon-Castillo","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.010_bib0012","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.prro.2024.05.010_bib0013","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.prro.2022.09.002","article-title":"Radiation therapy for endometrial cancer: an American Society for Radiation Oncology Clinical Practice Guideline","volume":"13","author":"Harkenrider","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.010_bib0014","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","article-title":"Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oaknin","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.prro.2024.05.010_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263585","article-title":"The clinicopathology and survival characteristics of patients with POLE proofreading mutations in endometrial carcinoma: a systematic review and meta-analysis","volume":"17","author":"Jumaah","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.prro.2024.05.010_bib0016","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/PAS.0000000000001020","article-title":"Molecular classification of grade 3 endometrioid endometrial cancers identifies distinct prognostic subgroups","volume":"42","author":"Bosse","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.prro.2024.05.010_bib0017","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1080\/0284186X.2019.1643036","article-title":"Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study","volume":"58","author":"Stalberg","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2024.05.010_bib0018","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ygyno.2006.06.013","article-title":"Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study","volume":"102","author":"Bell","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2024.05.010_bib0019","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","article-title":"Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer","volume":"380","author":"Matei","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2024.05.010_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ygyno.2023.11.012","volume":"180","author":"Barlin","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2024.05.010_bib0021","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ygyno.2023.04.010","article-title":"Cost-effectiveness analysis of tumor molecular testing in stage III endometrial cancer","volume":"173","author":"Orellana","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2024.05.010_bib0022","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ygyno.2021.10.071","article-title":"Cost-effectiveness analysis of tumor molecular classification in high-risk early-stage endometrial cancer","volume":"164","author":"Orellana","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.prro.2024.05.010_bib0023","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/cncr.33516","article-title":"Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: an individual patient data meta-analysis","volume":"127","author":"McAlpine","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2024.05.010_bib0024","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00428-023-03636-0","article-title":"Validation of Modaplex POLE mutation assay in endometrial carcinoma","volume":"483","author":"Dorca","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.prro.2024.05.010_bib0025","article-title":"QPOLE: A quick, simple, and cheap alternative for POLE sequencing in endometrial cancer by multiplex genotyping quantitative polymerase chain reaction","volume":"9","author":"Van den Heerik","year":"2023","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.prro.2024.05.010_bib0026","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/S2589-7500(22)00210-2","article-title":"Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts","volume":"5","author":"Fremond","year":"2023","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.prro.2024.05.010_bib0027","unstructured":"Health Equity. World Health Organization. Accessed 24 March 2024. https:\/\/www.who.int\/health-topics\/health-equity"},{"key":"10.1016\/j.prro.2024.05.010_bib0028","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ygyno.2023.09.009","article-title":"TP53 mutation and abnormal p53 expression in endometrial cancer: associations with race and outcomes","volume":"178","author":"Whelan","year":"2023","journal-title":"Gynecol Oncol"}],"updated-by":[{"DOI":"10.1016\/j.prro.2024.11.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000}}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850024001553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850024001553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:24:35Z","timestamp":1762561475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850024001553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1879850024001553"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2024.05.010","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International Federation of Gynecology and Obstetrics Endometrial 2023 Is Better For Radiation Oncology Patients","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2024.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Radiation Oncology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}